# A 24-Month Prospective Study of the Effects of Sleeve Gastrectomy on Glucose Homeostasis in Youth

**Authors:** Ana Paola Lopez Lopez, Imen Becetti, Meghan Lauze, Karen Olivar Carreno, Hang Lee, Vibha Singhal, Miriam A. Bredella, Madhusmita Misra

PMC · DOI: 10.3390/nu18050734 · Nutrients · 2026-02-25

## TL;DR

This study shows that sleeve gastrectomy improves glucose control in youth with obesity, mainly in the first year after surgery.

## Contribution

The study provides long-term data on glucose homeostasis changes in youth after sleeve gastrectomy over 24 months.

## Key findings

- Sleeve gastrectomy led to significant improvements in HbA1c, insulin, and insulin resistance within the first 12 months.
- Weight-related parameters decreased significantly in the surgical group compared to the non-surgical group over 24 months.
- Glucose homeostasis improvements stabilized after the first year, with no significant changes between 12 and 24 months.

## Abstract

Background: Metabolic and bariatric surgery (MBS) results in significant changes in weight and body composition, along with glucose homeostasis improvement and type 2 diabetes resolution. In youth, sleeve gastrectomy (SG) is the most frequently performed MBS. Long-term studies assessing the duration over which glucose homeostasis parameters improve after SG are sparse. Objective: To examine the duration over which SG impacts glucose homeostasis in youth. Methods: This 24-month prospective study enrolled 65 youth (49 females) with moderate–severe obesity (mean age 18.0 ± 0.3 years). A total of 28 underwent SG, while 37 non-surgical (NS) participants received routine lifestyle counseling. At baseline, 12- and 24-month follow-up visits, HbA1c, and fasting and post-prandial insulin and glucose levels at 15, 30, 60, 90, and 120 min following a mixed meal tolerance test were obtained, and body composition was assessed. Results: At baseline, SG vs. NS had higher weight, body mass index (BMI) and percent fat mass (p ≤ 0.019), but did not differ for glucose homeostasis parameters. Over 24 months, reductions in weight-related parameters were noted in SG vs. NS (p ≤ 0.0001). Over 12 and 24 months, improvements occurred in HbA1c, fasting insulin, Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), and the Matsuda index in SG vs. NS (p ≤ 0.002). However, the between-group difference for changes in glucose homeostasis parameters between 12 and 24 months was not significant. Conclusions: Improvements in glucose homeostasis occur mostly in the first year following SG, with subsequent stabilization of these measures.

## Linked entities

- **Diseases:** type 2 diabetes (MONDO:0005148), obesity (MONDO:0011122)

## Full-text entities

- **Genes:** INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}
- **Diseases:** Insulin Resistance (MESH:D007333), type 2 diabetes (MESH:D003924), obesity (MESH:D009765)
- **Chemicals:** Glucose (MESH:D005947)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12986720/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12986720/full.md

## References

36 references — full list in the complete paper: https://tomesphere.com/paper/PMC12986720/full.md

---
Source: https://tomesphere.com/paper/PMC12986720